Business
Johnson & Johnson Drives Innovation in Pulsed Field Ablation with Peru Launch
LIMA, Peru, March 16, 2026--Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a significant advance in the approach to cardiac arrhythmias, with benefits in terms of safety, precision, and procedural efficiency.1
About this update from Johnson & Johnson
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2690,"height":510,"url":"https://media.zenfs.com/en/business-wire.com/6da5c13fd83e11ebeb605d4fd6c3de47"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/I4ZAridMD55zbOhNn6t7Ow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE4MjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6da5c13fd83e11ebeb605d4fd6c3de47","width":960,"height":182},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/cixoFPEUX0PQGWSMjBtJlw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NTY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/6da5c13fd83e11ebeb605d4fd6c3de47","width":1200,"height":228}},"lazy":false},{"type":"text","content":"LIMA, Peru, March 16, 2026--(BUSINESS WIRE)--Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a significant advance in the approach to cardiac arrhythmias, with benefits in terms of safety, precision, and procedural efficiency.1","length":378,"tagName":"p"},{"type":"text","content":""With this launch, Peru joins the Latin American countries that already have this world-class innovation, used in international reference centers. In the country, institutions such as Clínica Delgado of the AUNA group will lead its implementation, consolidating Peru's positioning at the forefront of electrophysiology," says Silvina Romero, General Manager, Perú & Ecuador, MedTech, Johnson & Johnson. "The procedure was performed using VARIPULSE technology, currently under evaluation by the institution as part of its ongoing commitment to identifying innovations for patient treatment. This is how our presence in the region directly impacts the quality of life of the thousands of Peruvian patients living with atrial fibrillation."","length":769,"tagName":"p"},{"type":"text","content":"One of the most relevant differentiators of this innovation is that it is an integrated mapping and ablation system, allowing electrophysiologists to work with real-time visualization and immediate feedback during the procedure. This integration facilitates a more efficient, reproducible workflow with minimal fluoroscopy exposure, contributing to improved patient s...